SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 (SEM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001
Symbol
SEM on NYSE
Shares outstanding
124,068,451
Price per share
$14.95
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
100,336,028
Total reported value
$1,490,055,565
% of total 13F portfolios
0%
Share change
-388,955
Value change
-$1,094,717
Number of holders
267
Price from insider filings
$14.95
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 (SEM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% -19% $294,839,445 -$72,613,311 16,015,179 -20% BlackRock, Inc. 31 Mar 2025
ORTENZIO ROBERT A 11% 0% $209,595,038 14,019,735 0% ORTENZIO ROBERT A 23 Feb 2026
ORTENZIO ROCCO A 3.2% $75,214,976 4,085,550 Estate of Rocco A. Ortenzio 31 Dec 2024

As of 31 Dec 2025, 267 institutional investors reported holding 100,336,028 shares of SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 (SEM). This represents 81% of the company’s total 124,068,451 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 (SEM) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 18,703,734 -2.3% 0% $277,750,448
PRICE T ROWE ASSOCIATES INC /MD/ 13% 16,606,269 +4.3% 0.03% $246,604,000
VANGUARD GROUP INC 10% 12,477,780 -0.75% 0% $185,295,034
DIMENSIONAL FUND ADVISORS LP 4.3% 5,333,595 +2.6% 0.02% $79,204,582
STATE STREET CORP 3.5% 4,397,112 +0.2% 0% $65,297,113
GEODE CAPITAL MANAGEMENT, LLC 2.5% 3,117,638 +0.05% 0% $46,303,912
T. Rowe Price Investment Management, Inc. 2.3% 2,826,987 -1.1% 0.03% $41,981,000
D. E. Shaw & Co., Inc. 1.8% 2,211,898 +19% 0.02% $32,846,685
Western Standard LLC 1.7% 2,064,021 +96% 14% $30,650,712
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 1,686,737 +1.4% 0% $25,048,044
Woodline Partners LP 1.1% 1,340,197 +140% 0.08% $19,901,925
BANK OF AMERICA CORP /DE/ 1% 1,298,453 -22% 0% $19,282,026
NORTHERN TRUST CORP 1% 1,293,749 -4.4% 0% $19,212,173
Hood River Capital Management LLC 1% 1,266,887 -17% 0.21% $18,813,272
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.96% 1,185,399 0.03% $17,603,175
Bank of New York Mellon Corp 0.86% 1,062,284 -16% 0% $15,774,914
Prosight Management, LP 0.83% 1,035,086 +18% 3.2% $15,371,027
Invesco Ltd. 0.82% 1,022,061 -33% 0% $15,177,606
MORGAN STANLEY 0.78% 966,710 -21% 0% $14,355,665
ALGERT GLOBAL LLC 0.75% 927,397 +997% 0.21% $13,772,000
Eversept Partners, LP 0.73% 906,100 0.75% $13,455,585
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.64% 788,380 +7.1% 0.25% $11,707,443
Dana Investment Advisors, Inc. 0.55% 678,545 +29% 0.29% $10,076,393
Cambria Investment Management, L.P. 0.45% 557,494 0.48% $8,278,786
MILLENNIUM MANAGEMENT LLC 0.44% 548,153 -66% 0.01% $8,140,072

Institutional Holders of SELECT MEDICAL HOLDINGS CORP - Common Stock, par value $0.001 (SEM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 100,336,028 $1,490,055,565 -$1,094,717 $14.85 267
2025 Q3 100,630,018 $1,292,290,678 -$3,943,549 $12.84 264
2025 Q2 100,467,489 $1,525,083,959 -$89,875,058 $15.18 261
2025 Q1 106,587,834 $1,780,162,120 +$14,970,670 $16.70 272
2024 Q4 105,388,891 $1,986,844,341 +$42,067,914 $18.85 269
2024 Q3 99,334,828 $3,463,519,440 -$26,081,324 $34.87 282
2024 Q2 99,618,759 $3,492,995,625 +$18,268,271 $35.06 256
2024 Q1 99,503,977 $3,006,124,893 +$69,182,933 $30.15 250
2023 Q4 98,119,502 $2,306,204,585 +$18,779,961 $23.50 244
2023 Q3 97,233,591 $2,456,859,968 -$48,424,716 $25.27 245
2023 Q2 99,025,471 $3,154,155,784 -$116,781,236 $31.86 222
2023 Q1 102,689,349 $2,654,415,315 +$18,749,371 $25.85 212
2022 Q4 102,397,663 $2,542,784,716 +$25,549,153 $24.83 208
2022 Q3 101,488,474 $2,243,068,480 -$120,566,916 $22.10 206
2022 Q2 100,041,374 $2,363,545,334 -$68,482,910 $23.62 200
2022 Q1 103,694,537 $2,489,447,256 -$2,180,923 $23.99 226
2021 Q4 103,029,624 $3,030,122,771 -$40,766,909 $29.40 232
2021 Q3 103,646,590 $3,748,783,650 -$51,370,789 $36.17 241
2021 Q2 104,705,394 $4,424,067,823 +$58,675,339 $42.26 260
2021 Q1 103,635,773 $3,534,318,747 +$28,753,506 $34.10 250
2020 Q4 102,783,972 $2,843,553,415 +$31,305,197 $27.66 203
2020 Q3 101,854,148 $2,120,291,076 -$5,114,389 $20.82 187
2020 Q2 102,176,554 $1,504,986,527 -$14,643,588 $14.73 197
2020 Q1 103,342,430 $1,550,138,999 -$5,713,641 $15.00 207
2019 Q4 102,603,806 $2,394,699,156 -$3,309,945 $23.34 213
2019 Q3 103,339,735 $1,712,428,525 -$9,416,499 $16.57 180
2019 Q2 103,991,486 $1,650,257,879 +$14,435,361 $15.87 188
2019 Q1 104,036,299 $1,465,920,146 -$21,951,024 $14.09 197
2018 Q4 105,066,432 $1,613,226,001 -$2,892,006 $15.35 202
2018 Q3 104,383,799 $1,920,408,122 +$22,432,858 $18.40 191
2018 Q2 103,232,178 $1,873,755,098 +$6,252,776 $18.15 190
2018 Q1 102,763,926 $1,772,906,931 +$1,689,508 $17.25 194
2017 Q4 102,480,572 $1,808,697,106 +$28,386,455 $17.65 178
2017 Q3 105,162,450 $2,018,821,900 +$7,381,164 $19.20 177
2017 Q2 105,813,842 $1,624,436,801 -$18,998,054 $15.35 149
2017 Q1 107,529,085 $1,435,554,303 +$133,483,992 $13.35 159
2016 Q4 110,471,459 $1,463,987,011 +$7,750,907 $13.25 152
2016 Q3 109,766,739 $1,481,466,612 +$30,598,399 $13.50 155
2016 Q2 107,294,445 $1,167,964,833 +$3,106,468 $10.87 167
2016 Q1 106,595,310 $1,262,176,086 -$8,566,808 $11.81 151
2015 Q4 107,271,735 $1,277,369,361 +$35,144,464 $11.91 159
2015 Q3 105,982,997 $1,143,728,353 -$20,405,478 $10.79 162
2015 Q2 106,636,790 $1,727,518,825 +$65,949,546 $16.20 179
2015 Q1 102,245,360 $1,515,955,158 +$52,705,677 $14.83 157
2014 Q4 98,819,897 $1,423,070,595 +$50,487,952 $14.40 158
2014 Q3 95,610,561 $1,150,194,086 +$43,556,315 $12.03 166
2014 Q2 91,517,707 $1,426,323,254 +$114,157,897 $15.60 163
2014 Q1 84,700,960 $1,054,506,209 +$183,342,183 $12.45 140